Pieske, Burkert
German Centre for Cardiovascular Research · Charité – Universitätsmedizin Berlin
30 papers on CoChatORCID 0000-0002-6466-5306
Most cited papers
- Verified
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 11,429
- Verified
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 6,879
- Verified
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure
Heart Failure Treatment and ManagementClinical practice guidelines implementation
Cited by 5,866
- Verified · note
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal
Cardiomyopathy and Myosin StudiesCardiovascular Effects of Exercise
Cited by 4,332
- Verified
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 2,644
- Verified
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine
Heart Failure Treatment and ManagementRenin-Angiotensin System Studies
Cited by 2,430
- Verified
Periodontitis and cardiovascular diseases: Consensus report
Sanz, M., Marco del Castillo, A., Jepsen, S., Gonzalez‐Juanatey, J. R., D’Aiuto, F., Bouchard, P., Chapple, I., Dietrich, T., Gotsman, I., Graziani, F., et al. (2020) · Journal of Clinical Periodontology
Oral microbiology and periodontitis researchDental Research and COVID-19
Cited by 1,482
- Verified
Vericiguat in patients with heart failure and reduced ejection fraction
Armstrong, P. W., Pieske, B., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., Butler, J., Lam, C. S. P., Ponikowski, P., Voors, A. A., Jia, G., et al. (2020) · New England Journal of Medicine
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 1,358
- Verified
Cardioprotection and lifespan extension by the natural polyamine spermidine
Eisenberg, T., Abdellatif, M., Schroeder, S., Primessnig, U., Stekovic, S., Pendl, T., Harger, A., Schipke, J., Zimmermann, A., Schmidt, A., et al. (2016) · Nature Medicine
Polyamine Metabolism and ApplicationsGenetics, Aging, and Longevity in Model Organisms
Cited by 1,168
- Verified
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation
Cardiac electrophysiology and arrhythmiasCardiomyopathy and Myosin Studies
Cited by 535
- Verified
Ca2+Handling and Sarcoplasmic Reticulum Ca2+Content in Isolated Failing and Nonfailing Human Myocardium
Pieske, B., Maier, L. S., Bers, D. M., & Hasenfuss, G. (1999) · Circulation Research
Cardiac electrophysiology and arrhythmiasCardiovascular Function and Risk Factors
Cited by 369
- Verified
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Pieske, B., Maggioni, A. P., Lam, C. S. P., Pieske-Kraigher, E., Filippatos, G., Butler, J., Ponikowski, P., Shah, S. J., Solomon, S. D., Scalise, A.-V., et al. (2017) · European Heart Journal
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 366
- Verified
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
Mueller, S., Winzer, E. B., Duvinage, A., Gevaert, A. B., Edelmann, F., Haller, B., Pieske-Kraigher, E., Beckers, P., Bobenko, A., Hommel, J., et al. (2021) · JAMA
Cardiovascular and exercise physiologyHeart Failure Treatment and Management
Cited by 347
- Verified
. Effects of serelaxin in patients with acute heart failure
Metra, M., Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P. S., Ponikowski, P., Voors, A. A., et al. (2019) · New England Journal of Medicine
Heart Failure Treatment and ManagementPregnancy-related medical research
Cited by 282
- Verified
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document
Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure
Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials
Cited by 231
- Verified
Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling
Pieske, B., Sütterlin, M., Schmidt-Schweda, S., Minami, K., Meyer, M., Olschewski, M., Holubarsch, C., Just, H., & Hasenfuss, G. (1996) · Journal of Clinical Investigation
Cardiac electrophysiology and arrhythmiasCardiomyopathy and Myosin Studies
Cited by 184
- Verified · note
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
Ezekowitz, J. A., O’Connor, C. M., Troughton, R. W., Alemayehu, W. G., Westerhout, C. M., Voors, A. A., Butler, J., Lam, C. S. P., Ponikowski, P., Emdin, M., et al. (2020) · JACC: Heart Failure
Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling
Cited by 146
- Verified
Association of glucose metabolism with diastolic function along the diabetic continuum
Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H. D., Scherer, M., Kochen, M. M., Binder, L., Herrmann-Lingen, C., Gelbrich, G., et al. (2010) · Diabetologia
Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 141
- Verified
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments
Cited by 141
- Verified
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function
Wild, P. S., Felix, J. F., Schillert, A., Teumer, A., Chen, M.-H., Leening, M. J. G., Völker, U., Großmann, V., Brody, J. A., Irvin, M. R., et al. (2017) · Journal of Clinical Investigation
Genetic Associations and EpidemiologyCardiac electrophysiology and arrhythmias
Cited by 129
- Verified
A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): Results of an Observer-Blinded, Multicenter, Randomized Trial in Depressed Patients With Coronary Artery Disease
Herrmann-Lingen, C., Beutel, M. E., Bosbach, A., Deter, H.-C., Fritzsche, K., Hellmich, M., Jordan, J., Jünger, J., Ladwig, K.-H., Michal, M., et al. (2016) · Psychosomatic Medicine
Cardiac Health and Mental HealthAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 98
- Verified
Impact of obstructive sleep apnoea on diastolic function
Wachter, R., Lüthje, L., Klemmstein, D., Lüers, C., Stahrenberg, R., Edelmann, F., Holzendorf, V., Hasenfuß, G., Andreas, S., & Pieske, B. (2013) · European Respiratory Journal
Obstructive Sleep Apnea ResearchCardiovascular Function and Risk Factors
Cited by 93
- Verified
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis
Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure
Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling
Cited by 88
- Verified
2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy
Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., Mahrholdt, H., et al. (2015) · Revista Española de Cardiología (English Edition)
Coronary Interventions and DiagnosticsAcute Myocardial Infarction Research
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free